ARCHIVES

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

This article is from The Cancer Letter archive.

Vol. 12 No. 11 | March 14, 1986

Download PDF Visit The Full Archive

Related Articles

Small Study: Radiation, Chemo May Better Control Anal Cancer

November 26, 2010

In Brief: Ashworth Named Center Director at UCSF

March 21, 2014

“Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers

April 17, 1981

New CEO Brings Managed Care Expertise To Network Of Academic Cancer Centers

January 24, 1997

Panel Recommends Peer Review “Fine Tuning” Changes Including Mandatory Service By All NIH Grantees

January 6, 1984

A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs.

April 21, 2006